| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |